Achieve Life Sciences Inc (ACHV)
Healthcare
Biotechnology
6.40 $
+1.9%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Achieve Life Sciences Inc (ACHV)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 85.2% of the shares are freely tradable; institutional investors hold 61.0%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
61.0%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
0.9%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
85.2%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
14.4%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
103Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Franklin Resources Inc | 4.26 | 4,369,193 | +0.0 | 03/31/2026 |
| Propel Bio Management LLC | 3.69 | 3,786,425 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 2.15 | 2,204,714 | +0.0 | 03/31/2026 |
| Simplify Asset Management Inc. | 1.40 | 1,432,105 | +20.9 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Morn Total Stk Mkt Idx Investor | 3.03 | 3,108,369 | +98.5 | 06/30/2026 |
| iShares Russell 2000 ETF | 1.95 | 2,000,031 | +1.1 | 07/28/2026 |
| Franklin Biotechnology Discv A(acc)USD | 1.88 | 1,931,477 | -30.9 | 06/30/2026 |
| Simplify Propel Opportunities ETF | 1.40 | 1,432,105 | +0.0 | 07/29/2026 |
| State Street® SPDR® S&P® Biotech ETF | 1.30 | 1,339,064 | +0.6 | 07/29/2026 |
| Franklin Biotechnology Discovery A | 1.07 | 1,095,791 | -30.5 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.